Name | Sibrotuzumab |
---|
Description | Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC)[1]. |
---|---|
Related Catalog | |
References |
No Any Chemical & Physical Properties |